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embrane blebbing during the apoptotic execution
phase results from caspase-mediated cleavage
and activation of ROCK I. Here, we show that
ROCK activity, myosin light chain (MLC) phosphorylation,
MLC ATPase activity, and an intact actin cytoskeleton, but
not microtubular cytoskeleton, are required for disruption
of nuclear integrity during apoptosis. Inhibition of ROCK
or MLC ATPase activity, which protect apoptotic nuclear
integrity, does not affect caspase-mediated degradation
M
 
of nuclear proteins such as lamins A, B1, or C. The condi-
tional activation of ROCK I was sufﬁcient to tear apart
nuclei in lamin A/C null ﬁbroblasts, but not in wild-type
ﬁbroblasts. Thus, apoptotic nuclear disintegration requires
actin-myosin contractile force and lamin proteolysis, making
apoptosis analogous to, but distinct from, mitosis where
nuclear disintegration results from microtubule-based forces
and from lamin phosphorylation and depolymerization.
 
Introduction
 
Apoptosis leads to the death and subsequent removal of
damaged or redundant cells. Cysteine-proteases called caspases
are responsible for the apoptotic “execution” phase, which is
characterized by morphological changes including cell contrac-
tion, dynamic membrane blebbing, and nuclear disintegration.
Contractile force generated by actin-myosin cytoskeletal struc-
tures is the driving power behind cell contraction and the
formation of membrane blebs (Coleman and Olson, 2002). In
the apoptotic cell, the disintegrated nucleus is found within
blebs and packaged into membrane-clad apoptotic bodies that
facilitate uptake by neighboring cells or by specialized phago-
cytic cells. The release of nuclear fragments from apoptotic
cells is believed to be the source of antigens in autoimmune
diseases such as systemic lupus erythematosus (Rosen and
Casciola-Rosen, 1999; Stollar and Stephenson, 2002).
The dynamic contraction and membrane blebbing seen
in apoptotic cells are dependent on intracellular force gener-
ated by the actin-myosin cytoskeleton. These morphological
events are controlled by the Rho effector ROCK I, a serine/
threonine kinase that plays a key and central role in the regulation
of actin cytoskeletal structures. We and others showed that
caspase-mediated cleavage of ROCK I results in constitutive
activation and consequent myosin light chain (MLC) phos-
phorylation leading to contraction and membrane blebbing
(Coleman et al., 2001; Sebbagh et al., 2001). Inhibition of
ROCK activity with the small molecule inhibitor Y-27632
attenuated blebbing in a variety of cell types, independent of
the type of apoptotic stimulus. Inhibition of ROCK activity
also prevented the relocalization of fragmented DNA into
membrane blebs and apoptotic bodies (Coleman et al., 2001),
suggesting additional roles for ROCK in the morphological
changes that occur during apoptosis.
In addition to the gross external morphological responses,
there are significant effects on the morphology and integrity of
organelles, the most obvious being nuclear disintegration.
Separating the nucleus from the cytoplasm is the nuclear enve-
lope, which is comprised of outer and inner nuclear membranes.
Giving the nucleus form, structure, and rigidity is a filamentous
meshwork called the lamina, which is made up from intermediate
filament A-type (A and C, alternately spliced products from the
 
Lmna
 
 gene) and B-type (B1, B2, and B3) lamins. Caspase-
mediated cleavage of lamins A/C and B1 is thought to contribute
to nuclear fragmentation during apoptosis (Neamati et al.,
1995; Rao et al., 1996; Broers et al., 2002).
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Ultrastructural analysis has shown that the nucleus is sur-
rounded by a meshwork of actin (Clubb and Locke, 1998b),
with “knots” of actin physically associated with the nuclear en-
velope (Clubb and Locke, 1998a). Disruption of the actin cyto-
skeleton alters nuclear morphology (Zhen et al., 2002), while
mutations to Anc-1/Syne family actin-binding proteins result
in aberrant nuclear anchoring (Starr and Han, 2003), indicat-
ing that the actin cytoskeleton influences nuclear positioning,
shape, and structure. Therefore, one possibility is that during
apoptosis, active caspase-cleaved ROCK I leads to shortening
of actin-myosin filaments that are tethered to the nucleus at one
end, resulting in nuclear envelope tearing and disintegration,
thereby allowing for the relocalization of fragmented DNA to
membrane blebs and apoptotic bodies (Coleman et al., 2001).
Mitotic nuclear envelope breakdown also requires weakening
of the nuclear lamina and a pulling force, but is mediated by
phosphorylation-induced depolymerization of the nuclear lam-
ina (Heald and McKeon, 1990) and microtubule-anchored pull-
ing force generated by the minus-end–directed motor, cyto-
plasmic dynein, and components of its associated regulatory
complex, dynactin (Beaudouin et al., 2002; Salina et al., 2002).
In this work, we examined the contribution of ROCK ac-
tivity and MLC phosphorylation to nuclear disintegration dur-
ing apoptosis. We found that ROCK activity, intact actin fila-
ments, MLC phosphorylation, and MLC ATPase activity are
each required for the breakdown of nuclear structure, whereas
intact microtubules are dispensable. Caspase-mediated cleav-
age of lamins A/C and B1 is not sufficient for nuclear disinte-
gration in the absence of ROCK and MLC ATPase activity. In
addition, conditional activation of ROCK I induces nuclear
breakdown in nonapoptotic cells only in the absence of lamin
A/C expression. These results indicate that apoptotic nuclear
breakdown requires weakening of the nuclear lamina by pro-
teolytic cleavage and the contractile force generated by ROCK
on actin-myosin filaments. Thus, apoptotic nuclear breakdown
parallels mitotic nuclear breakdown in the requirements for
lamina disassembly and generation of pulling force, but differs
in the means by which these events are achieved.
 
Results
 
ROCK activity and nuclear disintegration
 
We previously observed by TUNEL that in apoptotic cells
treated with the ROCK inhibitor Y-27632, fragmented DNA
was located within discrete foci and not in membrane blebs or
apoptotic bodies as in untreated apoptotic cells (Coleman et al.,
2001). Therefore, in addition to plasma membrane blebbing, we
hypothesized that ROCK activation by caspase-mediated cleav-
age promotes apoptotic nuclear disintegration, thereby allowing
fragmented DNA to be released from the nuclear compartment.
We used transmission EM (TEM) to obtain fine-detailed
photomicrographs of nuclear morphology during apoptosis.
NIH 3T3 mouse fibroblasts were treated with 25 ng/ml TNF
 
 
 
plus 10 
 
 
 
g/ml cycloheximide (CHX) for 2 h as the apoptotic
stimulus, and then processed for TEM. A typical apoptotic cell
is shown in Fig. 1 A, with membrane blebs, chromatin conden-
sation, and a significantly fragmented nucleus with large invag-
inations of the nuclear envelope and evidence of electron-dense
heterochromatin within the cytoplasm and in blebs (Fig. 1 A,
arrows). In contrast, cells given the ROCK inhibitor Y-27632
(10 
 
 
 
M) in conjunction with TNF
 
 
 
/CHX did not bleb and the
nucleus remained intact, although chromatin condensation and
nuclear envelope dilation were evident (Fig. 1 B). Consistent
with our previous observations (Coleman et al., 2001), hetero-
chromatin was retained within the nucleus, indicating that the
nuclear envelope remained a barrier to macromolecules.
 
Phosphorylation of ROCK substrates
 
We and others previously demonstrated that ROCK I be-
comes cleaved and activated in apoptotic cells (Coleman et
al., 2001; Sebbagh et al., 2001). The cleavage of ROCK I
(Fig. 1 C, cleaved form indicated by gray arrow and 
 
 
 
) is ac-
companied by increased phosphorylation of type II MLC on
residues Thr18 and Ser19 (Fig. 1 D), which is critical for as-
sociation of MLC with actin filaments and generation of con-
tractile force. MLC phosphorylation could be blocked with
the ROCK inhibitor Y-27632 (Fig. 1 D) or by blocking
ROCK I cleavage (Fig. 1 C) by pretreating cells with the cas-
pase inhibitor z-VAD-fmk before the induction of apoptosis
with TNF
 
 
 
. The myosin binding subunit (MYPT1) of the
MLC phosphatase has been reported to be phosphorylated by
ROCK on Thr696, which results in inhibition of MLC de-
phosphorylation (Feng et al., 1999; Kawano et al., 1999). Us-
ing a phospho-specific antibody against Thr696, no signifi-
cant change in phosphorylation was observed (Fig. 1 E, top);
however, one major and one minor (Fig. 1 E, gray arrows)
proteolytic fragment were observed. MYPT1 cleavage was
not apparently changed by Y-27632 but could be prevented
with z-VAD-fmk. An antibody raised against the amino ter-
minus of MYPT1 revealed a loss of immunoreactivity in ap-
optotic cells, indicating that the cleavage occurred at the
amino-terminal end (Fig. 1 E, bottom). Analysis of protein
mobility on SDS-PAGE revealed that 
 
 
 
80 amino acids were
removed from the cleaved fragment. Deletion analysis of
MYPT1 has shown that the amino-terminal region is respon-
sible for binding both MLC and the catalytic subunit of the
phosphatase complex. Therefore, cleavage of the 
 
 
 
80 amino
acids from the MYPT1 amino terminus would likely inacti-
vate the MLC dephosphorylating activity and commit the ap-
optotic cell to irrevocable MLC phosphorylation.
Additional downstream substrates of ROCK that may
contribute to actin-myosin contractility are the LIM kinases
(LIMK) 1 and 2 (Ohashi et al., 2000; Sumi et al., 2001). Over-
expression of LIMK2 has been reported to induce the forma-
tion of stress fibers and membrane blebs (Amano et al., 2001),
suggesting that LIMK1/2 activation contributes to the apop-
totic morphology. Using an antibody that detects phosphoryla-
tion of a Thr residue in the conserved activation loops of
LIMK1 (Thr508) and LIMK2 (Thr505), we observed increased
phosphorylation following the induction of apoptosis, which
could be blocked with ROCK inhibitor Y-27632 or by inhibi-
tion of ROCK I cleavage with z-VAD-fmk (Fig. 1 F). These re-
sults indicate that LIMK activation may contribute to ROCK-
mediated morphological effects in apoptotic cells. 
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We also examined how the induction of apoptosis af-
fected the phosphorylation state of Ezrin, which acts as a
linker between actin filaments and transmembrane proteins
such as CD44, thereby providing an anchoring point in the
plasma membrane for actin-myosin fibers. ROCK-induced
contraction of NIH 3T3 cells was reported to be dependent on
phosphorylation of Ezrin Thr567 (Tran Quang et al., 2000),
which allows for dissociation of inter- and/or intramolecular
interactions and association with actin filaments (Gautreau et
al., 2000). Using an antibody specific for Ezrin phosphory-
lated on Thr567, no changes in the phosphorylation status
were observed in apoptotic cells or after Y-27632 treatment
(Fig. 1 G), indicating that ROCK-mediated phosphorylation of
Ezrin on Thr567 does not contribute to apoptotic cell contrac-
tion. Treatment of cells with the general kinase inhibitor stau-
rosporine (0.2 
 
 
 
M) for 30 min eliminated Ezrin T567 phos-
phorylation, suggesting that kinases other than ROCK are
responsible for basal phosphorylation.
 
Nuclear disintegration and the actin and 
microtubule cytoskeletons
 
Next, we determined whether or not, in addition to ROCK ac-
tivity, an intact actin cytoskeleton was required for nuclear
disruption. Pretreatment with the actin-destabilizing compound
cytochalasin D (2 
 
 
 
M; Sampath and Pollard, 1991) for 2 h
before treatment with TNF
 
 
 
/CHX disrupted the actin cytoskel-
eton (Fig. 2 A) and blocked fragmentation of the nucleus (Fig.
2 B). Similar results (unpublished data) were obtained when
the actin cytoskeleton was disrupted with swinholide A (0.1
 
 
 
M; Bubb et al., 1995) or latrunculin B (0.5 
 
 
 
M; Spector et al.,
1983). These results indicate that an intact actin cytoskeleton is
necessary to mediate nuclear disintegration. Disruption of the
cytoskeleton with cytochalasin D did not affect caspase 3 acti-
vation (Fig. 2 C) and cleavage of ROCK I (Fig. 2 D) or poly-
ADP ribose polymerase (PARP; Fig. 2 E), which is consis-
tent with the lack of effect of Y-27632 on caspase activation
(Fig. 1, C and E).
Figure 1. Apoptotic nuclear breakdown is blocked following ROCK inhibition. (A) Transmission electron micrograph of an NIH 3T3 fibroblast treated with
25 ng/ml TNF  plus 10  g/ml cycloheximide (CHX) for 2 h to induce apoptosis, showing large plasma membrane blebs, nuclear disintegration, and hetero-
chromatin within blebs (arrows). Bar, 5  m. (B) TEM of cells treated with 10  M Y-27632 to block ROCK activity along with TNF /CHX showing an
absence of blebs and preservation of nuclear envelope integrity. Inset in left panel shown in right panel. Bars, 2  m. (C–G) Serum-starved NIH 3T3 fibro-
blasts were left untreated or treated with 25 ng/ml TNF  plus 10  g/ml CHX for 2 h to induce apoptosis, either in the absence or presence of 10  M
Y-27632 or 50  M z-VAD-fmk as indicated. Lysates were prepared by direct lysis in 1  Laemmli sample buffer and samples run on 10% SDS-PAGE.
Western blotting with antibodies against ROCK I (C), myosin light chain (MLC; D, bottom), and dually phosphorylated Thr18 Ser19 MLC (D, top), myosin
binding subunit of the MLC phosphatase (MYPT1; E, bottom), and phosphorylated Thr696 MYPT1 (E, top), the common epitope of phospho-LIMK1
(Thr508; F) and phospho-LIMK2 (Thr505; F), and Ezrin (G, bottom) and phosphorylated Ezrin (Thr567; G, top). Phosphorylation of MLC and LIMK1/2
in apoptotic cells was blocked by ROCK inhibitor Y-27632 and by preventing caspase-mediated ROCK I cleavage with z-VAD-fmk. No differences in
MYPT1 or Ezrin phosphorylation were evident, although MYPT1 was cleaved in a z-VAD-fmk–sensitive manner in apoptotic cells, removing  80 amino
acids from the amino-terminal end. 
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To determine whether or not an intact microtubule net-
work is required for apoptotic nuclear breakdown, microtu-
bules were disrupted by pretreatment with nocodazole (1 
 
 
 
M)
for 2 h before treatment with TNF
 
 
 
 plus CHX for an additional
2 h. Despite efficient disruption of the microtubule network
(Fig. 3 B), nocodazole treatment did not prevent apoptotic
membrane blebbing or nuclear breakdown (Fig. 3 C). These
data indicate that nuclear disruption in apoptotic cells differs
from mitotic nuclear breakdown in that the actin, and not mi-
crotubular, cytoskeleton provides the framework for mechani-
cal force that leads to nuclear tearing and rupture.
 
MLC phosphorylation and ATPase 
activity
 
Intact actin filaments and MLC phosphorylation have been
shown to be required for plasma membrane blebbing (Coleman
and Olson, 2002). Given that ROCK I is cleaved and MLC
phosphorylation is elevated in apoptotic cells, the requirement
Figure 2. Apoptotic nuclear breakdown is blocked following actin filament
disruption. (A) Actin filaments were apparent in untreated NIH 3T3 cells
(left), but cell morphology and actin filaments were profoundly affected
by treatment with 2  M cytochalasin D (right). Bars, 20  m. (B) TEM of
cell pretreated with 2  M cytochalasin D to disrupt actin structures before
induction of apoptosis, showing intact nucleus. Bar, 2  m. (C) Activation
of Caspase 3 and cleavage of ROCK I (D) and PARP (E) were not affected
by cytochalasin treatment and disruption of the actin cytoskeleton before
the induction of apoptosis. (F) Blotting for  -tubulin indicates equal load-
ing across lanes.
Figure 3. Disruption of microtubular structures does not affect apoptotic
nuclear breakdown. Microtubular structures were visualized with antibody
against anti– -tubulin antibody in untreated (A) or nocodazole (1  M; B)-
treated NIH 3T3 cells. (C) TEM of cell pretreated with 1  M nocodazole
to disrupt microtubules, as in B, before induction of apoptosis, showing
marked blebbing and nuclear disintegration. Bar, 2  m. 
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for MLC phosphorylation in apoptotic nuclear disintegration
was examined. Expression of MLC with alanine substitutions
at Thr18 and Ser19 has previously been shown to block actin
bundling and contractility (Iwasaki et al., 2001). NIH 3T3 cells
were transfected with plasmids encoding GFP, wild-type rat
MLC with carboxyl-terminally fused GFP, or the MLC(TASA)
double mutant fused with GFP (Fig. 4 A). Approximately 10–
12% of GFP-positive cells were selected (Fig. 4 A, R3), all of
which had greater fluorescence intensity than the autofluores-
cence of untransfected cells (Fig. 4 A, R4, blue peak). Post-sort-
ing analysis revealed the GFP-positive population to be 99%
pure (unpublished data). Equal aliquots of GFP-, MLC-GFP–,
and MLC(TASA)-GFP–positive cells were Western blotted
with GFP and 
 
 
 
-tubulin antibodies (Fig. 4 B) revealing approxi-
mately equal protein expression. Sorted cells were plated in me-
dium containing 10% fetal calf serum for 5 h, placed in serum-
free medium for 18 h, and apoptosis induced with TNF
 
 
 
 and
CHX treatment, and then cells were collected, fixed, and pro-
cessed for TEM. Cells expressing GFP (not depicted) or MLC-
GFP (Fig. 4 C) were typically apoptotic, with plasma membrane
blebs and disintegration of nuclei, often with portions of hetero-
chromatin visible within blebs (Fig. 4 C, arrows). In marked
contrast, cells expressing MLC(TASA)-GFP were typified by
an absence of plasma membrane blebs and possessed intact nu-
clei (Fig. 4 D). In addition, MLC(TASA)-GFP–expressing cells
contained long, apparently membrane enclosed, structures. The
origin of these membranous structures is currently under inves-
tigation. These results demonstrate that MLC phosphorylation
is required for nuclear disintegration in apoptotic cells.
Cell contraction is dependent on the myosin ATPase,
which through an ATP-dependent process catalyzes the short-
ening of actin-myosin filaments. Blebbistatin is a recently
developed inhibitor of nonmuscle myosin II function that
will most likely supplant the nonselective inhibitor butanedi-
one monoxime (BDM) as the inhibitor of choice. We tested
whether the ATPase activity of myosin was required for apop-
totic nuclear disintegration by coadministering blebbistatin (50
 
 
 
M) along with the TNF
 
 
 
 plus CHX apoptotic stimulus for 2 h.
As can be seen in Fig. 5 A, inhibition of myosin ATPase activ-
ity inhibited apoptotic nuclear breakdown and resulted in the
formation of elongated cytoplasmic structures, similar to those
seen in MLC(TASA)-GFP–expressing cells. Blebbistatin did
Figure 4. MLC phosphorylation is required for apoptotic nuclear disintegration. NIH 3T3 fibroblasts were transfected with a plasmid encoding GFP,
myosin light chain fused to GFP (MLC-GFP), or MLC doubly mutated to Ala at the phosphorylation sites Thr18 Ser19 (MLC(TASA)-GFP). After allowing
24 h for protein expression, cells were sorted for GFP expression. (A) Autofluorescence of untransfected cells is indicated as R4, sorting was gated such that
only GFP-positive cells with fluorescence intensity greater than all cells in R4 were collected (indicated as R3 in MLC-GFP and MLC(TASA)-GFP sorting profiles;
GFP profile not depicted). Post-sorting analysis indicated that sorted cells were 99% GFP-positive. (B) Lysates prepared from equal numbers of GFP-positive
cells were Western blotted for GFP to confirm equal protein expression (top) and for  -tubulin to confirm equal protein loading (bottom). (C) Cells were plated
in medium containing 10% FCS for 5 h, and then placed in serum-free medium for 18 h. Apoptosis was induced with 25 ng/ml TNF  plus 10  g/ml CHX
for 2 h, and then nonadherent apoptotic cells were collected, fixed, and processed for TEM. Expression of GFP (not depicted) or MLC-GFP did not affect
nuclear disintegration in apoptotic cells (arrows indicate heterochromatin in blebs). Bar, 2  m. (D) Expression of nonphosphorylatable MLC(TASA)-GFP
inhibited plasma membrane blebbing and nuclear fragmentation, although typical apoptotic chromatin condensation was evident. Bar, 2  m. 
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not affect ROCK I cleavage (Fig. 5 B) or LIMK phosphoryla-
tion (Fig. 5 C), which is consistent with the protective effect on
nuclear integrity being the result of myosin ATPase inhibition.
 
Caspase cleavage of nuclear proteins
 
The nucleus is separated from the cytoplasm by a nuclear enve-
lope composed of outer and inner nuclear membranes that are
joined at nuclear pore complexes (for review see Burke and El-
lenberg, 2002). Underlying the inner nuclear membrane is the
nuclear lamina, composed of A-type and B-type lamins that form
a fibrous meshwork. Chromosomes associate with the lamina via
lamin-associated proteins (LAP), which are either integral mem-
brane proteins or soluble chromatin-associated proteins such as
LAP2
 
 
 
. Apoptotic nuclear disintegration is associated with cas-
pase-mediated proteolysis of nuclear proteins, particularly the
lamins B1 and A/C, which leads to the destabilization of the
structural elements that preserve the integrity of the nucleus
(Neamati et al., 1995). Given that lamin phosphorylation by pro-
tein kinases C
 
 
 
 (Shimizu et al., 1998), 
 
 
 
II (Chiarini et al., 2002),
or 
 
 
 
 (Cross et al., 2000) has been reported to be required for sub-
sequent caspase-mediated cleavage, we wished to determine if
inhibition of ROCK activity with Y-27632 prevented apoptotic
nuclear disintegration by interfering with nuclear protein cleav-
age. Lysates from NIH 3T3 cells that were untreated, treated
with TNF
 
 
 
/CHX either without or with Y-27632, or treated with
TNF
 
 
 
/CHX after a 2-h pretreatment with the general caspase in-
hibitor z-VAD-fmk (50 
 
 
 
M) were prepared and analyzed by
Western blotting. Lamins A/C (Fig. 6 A) and B1 (Fig. 6 B) levels
were significantly reduced after TNF
 
 
 
 treatment with the gener-
ation of a faster mobility fragment of lamin B1 (indicated by 
 
 
 
),
even in the presence of Y-27632. Inhibition of caspase activity
with z-VAD-fmk fully protected lamins A/C and B1 from cleav-
age. Treatment with cytochalasin D or blebbistatin also had no
effect on lamin B1 cleavage (unpublished data). We also ob-
served that the generation of cleaved forms (
 
 
 
) of LAP2
 
 
 
 (Fig. 6
C), nuclear pore protein Nup153 (Fig. 6 D), and PARP (Fig. 6 E)
were unaffected by Y-27632 administration but fully protected
by z-VAD-fmk. These results indicate that degradation of the
constituent proteins of the nuclear lamina and nuclear pore com-
plexes, as well as soluble nuclear proteins, does not require
ROCK activity. By inference, these results indicate that degrada-
tion of nuclear proteins is not sufficient for apoptotic nuclear dis-
integration in the absence of contractile force induced by ROCK.
Figure 5. Inhibition of myosin ATPase activity protects apoptotic nuclear
integrity. (A) NIH 3T3 cells were coadministered blebbistatin (50  M)
along with the TNF  plus CHX apoptotic stimulus for 2 h before collection
and processing for TEM. Bar, 2  m. NIH 3T3 fibroblasts were untreated
or treated with 50  M blebbistatin to inhibit myosin ATPase activity or 50
 M z-VAD-fmk to inhibit caspase activity as indicated. Apoptosis was
induced with TNF /CHX where indicated. Lysates were prepared and
Western blotted with antibodies against ROCK I and PARP (B) and phos-
pho-LIMK1 and 2 (C). Blebbistatin affects apoptotic nuclear morphology
without inhibiting caspase-mediated proteolysis or ROCK activity.
Figure 6. Degradation of nuclear lamins A/C and B1, LAP2 , Nup153,
and PARP during apoptosis is unaffected by ROCK inhibition. NIH 3T3
fibroblasts were left untreated or treated with 10  M Y-27632 to inhibit
ROCK activity or 50  M z-VAD-fmk to inhibit caspase activity as indicated.
Apoptosis was induced with TNF /CHX where indicated. Lysates were
prepared and Western blotted with antibodies against lamins A and C
(A), lamin B1 (B), LAP-2  (C), Nup-153 (D), and PARP (E). Equal loading
was verified with an antibody against  -tubulin. 
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Active ROCK I affects nuclear 
morphology
 
We wished to determine whether or not the contractile forces
generated by active ROCK I were sufficient to induce nuclear
disintegration in nonapoptotic cells. NIH 3T3 cells were trans-
duced either with a retroviral vector encoding amino acids
2–537 of human ROCK I fused to the hormone-binding domain
of the estrogen receptor (ROCK I:ER) or with a kinase-dead
version (KD:ER) in which Lys105 was mutated to glycine,
similar to ROCK II:ER fusion proteins we have used previ-
ously (McMullan et al., 2003; Croft et al., 2004). Estrogen re-
ceptor fusion proteins have been previously used to produce
conditionally active kinases (McMahon, 2001) that can be
stimulated by estrogen analogues such as tamoxifen or
4-hydroxytamoxifen (4-HT). The addition of 1 
 
 
 
M 4-HT for
18 h specifically activated ROCK I:ER resulting in MLC (Fig.
7 A) and LIMK1/2 phosphorylation (Fig. 7 B), which could be
blocked by the ROCK inhibitor Y-27632 (10 
 
 
 
M). Further
confirmation that the effect of 4-HT on MLC and LIMK1/2
phosphorylation resulted from activation of ROCK I:ER was
the lack of effect in parental NIH 3T3 or KD:ER-expressing
cells (Fig. 7, A and B). Expression of the ROCK I:ER fusion
protein was confirmed by Western blotting with anti-ER
 
 
 
 anti-
body, revealing no expression in parental NIH 3T3 cells and
comparable levels in KD:ER- and ROCK I:ER-expressing cells
that were elevated approximately twofold by 4-HT treatment
(Fig. 7 C), whereas blotting with anti-ERK2 antibody con-
firmed equal protein loading (Fig. 7 D). These results indicate
that conditional ROCK I:ER activation resulted in phosphory-
lation of proteins also found to be phosphorylated in apoptotic
cells in a Y-27632–sensitive manner, which is consistent with
the conclusion that these modifications during apoptosis are a
consequence of ROCK I cleavage and activation.
We next used ROCK I:ER to examine the effects of
ROCK activation on nuclear morphology and integrity. Consis-
tent with previous findings (Coleman et al., 2001; Sebbagh et
al., 2001), conditional activation of ROCK I:ER with 4-HT, in
the absence of apoptosis (cells were pretreated with z-VAD-
fmk), resulted in contraction and induction of membrane
blebbing in 
 
 
 
50% of ROCK I:ER-expressing NIH 3T3 cells
(Fig. 8 A, F-Actin left panels), which could be blocked by
coadministration of ROCK inhibitor Y-27632 (Fig. 8 A,
F-actin bottom panels). Treatment of parental NIH 3T3– or
KD:ER–expressing cells with 4-HT did not affect actin struc-
tures or cell morphology (not depicted), which is consistent
with the lack of effect on MLC or LIMK1/2 phosphorylation
(Fig. 7). Staining with anti–lamin B1 antibody revealed that
nuclei in contracted, ROCK I:ER-activated cells were smaller
and occasionally distorted, similar to previous findings that ex-
pression of active ROCK II can alter gross nuclear morphology
(Leung et al., 1996). These morphological changes were blocked
by Y-27632. Although sufficient to induce contractility and
membrane blebbing, these data illustrate that ROCK activation
is not sufficient for nuclear disruption.
Next, we tested whether or not ROCK I:ER-induced con-
tractility was sufficient for nuclear disruption under conditions in
which the tensile strength provided by an intact lamina is re-
duced. Lamin A/C null mouse embryo fibroblasts (MEFs), which
have a significant frequency of distorted nuclei with herniations
(Sullivan et al., 1999), and wild-type MEFs were transduced with
ROCK I:ER or KD:ER retrovirus. Treatment of ROCK I:ER-
expressing cells with 4-HT plus z-VAD-fmk resulted in in-
creased actin stress fibers, and frequent cell contraction accom-
panied by membrane blebbing, which could be blocked by the
ROCK inhibitor Y-27632 (Fig. 8, B and C, F-actin). Similar to
NIH 3T3 cells, KD:ER-expressing MEFs did not display changes
in actin structures or morphology after 4-HT treatment (unpub-
lished data). Nuclei in contracted blebbing wild-type MEFs were
smaller than spread or untreated cells (Fig. 8 B), similar to nuclei
in 4-HT–treated ROCK I:ER-expressing NIH 3T3 cells (Fig. 8
A). In marked contrast, lamin A/C null MEFs treated with 4-HT
plus z-VAD-fmk that contracted and blebbed had significantly
disrupted nuclei (Fig. 8 C), an effect that was blocked by
Y-27632. Staining by TUNEL showed no detectable DNA frag-
mentation (unpublished data), which is consistent with the nu-
clear disruption being a direct effect of ROCK and not resulting
from the induction of apoptosis. These results indicate that nuclei
weakened by deletion of an important component of the lamina
are disrupted by ROCK-induced cell contraction. Therefore, two
elements are required for nuclear disruption, contractile force
generated by active ROCK and weakening of the nuclear lamina,
both of which occur in apoptotic cells through caspase-mediated
cleavage of ROCK I and nuclear lamins.
Cell contraction, blebbing, and nuclear disruption in
lamin A/C null MEFs occurred after 4-HT–induced activation
Figure 7. Conditionally active ROCK I:ER induces MLC and LIMK1 and 2
phosphorylation when stimulated with 4-HT. NIH 3T3 cells were left
untreated or transduced with retrovirus encoding the conditionally active
ROCK I:ER or kinase-dead KD:ER fusion proteins as indicated. After selection,
stable pools were left untreated or treated with 1  M 4-hydroxytamoxifen
(4-HT) for 18 h as indicated, either in the absence or presence of ROCK
inhibitor Y-27632 (10  M). The phosphorylation status was examined with
antibodies against MLC (A; dual Thr18/Ser19 phosphorylation, top panel;
total MLC, bottom panel) and LIMK1 and 2 (B; LIMK1 Thr508, LIMK2
Thr505 phosphorylation, top panel; total LIMK 1, bottom panel). (C) Expres-
sion of KD:ER and ROCK I:ER confirmed by blotting with ER  antibody.
(D) Equal protein levels confirmed by blotting with ERK2 antibody. 
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of ROCK I:ER in the presence of caspase inhibitor z-VAD-
fmk, which is consistent with these effects being directly in-
duced and not secondarily through the induction of apoptosis.
Western blotting of lysates prepared from ROCK I:ER- and
KD:ER-expressing wild-type and lamin A/C null fibroblasts
revealed no evidence of lamin B1 (a caspase 6 substrate; Fig. 9
A) or PARP (a caspase 3 substrate; Fig. 9 B) cleavage, which
were readily detectable in cells made apoptotic by TNF
 
 
 
/CHX
treatment. Western blotting for lamin A/C confirmed the ab-
sence of expression in the lamin A/C null cells (not depicted),
whereas blotting for 
 
 
 
-tubulin and ERK2 showed protein load-
ing (Fig. 9, A and C). These results reinforce the conclusion
that ROCK I:ER-mediated contraction is sufficient to induce
nuclear disruption in nuclei with compromised lamina struc-
tures independent of caspase activation.
 
Discussion
 
Nuclear fragmentation is one of the classical hallmarks of
apoptosis originally described by Kerr et al. (1972) three
decades ago. Early studies concluded that caspase-mediated
cleavage of nuclear structural proteins was sufficient for apop-
totic nuclear disintegration (Neamati et al., 1995). However,
we now show that in the absence of ROCK activity, MLC
phosphorylation, or an intact actin cytoskeleton, the proteolysis
of lamins, lamin-associated, and pore proteins is not sufficient
for nuclear disintegration during apoptosis. Caspase-mediated
cleavage of lamins B1 and A/C, Nup153, LAP2
 
 
 
, and PARP
occurred to the same extent in apoptotic cells with disinte-
grated nuclei or in ROCK inhibitor-treated cells with intact nu-
clei, indicating that proteolysis of nuclear proteins is not suffi-
cient to rupture the nucleus during apoptosis. In addition,
expression of conditionally active ROCK I:ER induced mem-
brane blebbing and distortion of nuclear morphology without
causing nuclear disintegration in NIH 3T3 and primary MEFs.
However, genetic deletion of lamin A/C, which weakens the
nuclear lamina occasionally resulting in spontaneous hernia-
tions (Sullivan et al., 1999), allowed ROCK-induced contrac-
tion to disrupt nuclear integrity. We propose that during apop-
tosis, cleavage of nuclear lamins A/C and B1 weakens the
lamina and makes the nuclear envelope susceptible to tearing
Figure 8. Active ROCK I induces contraction and membrane blebbing, but
nuclear disruption only in lamin A/C null cells. Activation of ROCK I:ER with
4-HT resulted in increased filamentous actin structures and profound
morphological responses. (A) ROCK I:ER-expressing NIH 3T3 cells had
increased actin structures accompanied by cell contraction and membrane
blebbing in  50% of cells after treatment with 1  M 4-HT, either in the
presence (middle panels) or absence (not depicted) of z-VAD-fmk.
Coadministration of ROCK inhibitor Y-27632 blocked the effects on actin
structures and morphological responses (bottom panels). Nuclear morphology
and integrity was assessed by staining for lamin B1 (middle column), ROCK-
induced contraction and blebbing also resulted in contracted and distorted
nuclei that remained intact (middle row), which could be blocked by
ROCK inhibitor Y-27632 (bottom row). (B) Primary wild-type mouse embryo
fibroblasts (MEFs) transduced with ROCK I:ER responded to 4-HT treatment
with increased filamentous actin structures and many contracted, blebbing
cells (middle row), responses that could be blocked by ROCK inhibitor
Y-27632 (bottom row). ROCK-induced contraction and blebbing also re-
sulted in contraction of nuclei (middle column) as determined by lamin B1
staining. (C) Primary lamin A/C null MEFs transduced with ROCK I:ER also
responded to 4-HT with increased filamentous actin structures, cell contraction,
and membrane blebbing (middle row), which could be blocked with ROCK
inhibitor Y-27632. Nuclei (middle column) in contracted blebbing cells were
severely distorted and often disrupted, even in the presence of z-VAD-fmk
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by actin-myosin filaments, which contract due to caspase-acti-
vation of ROCK I. This proposed mechanism is analogous to,
but distinct from, mitotic nuclear breakdown, which is medi-
ated by phosphorylation-induced depolymerization of the nu-
clear lamina (Heald and McKeon, 1990) and microtubule-
anchored pulling force generated by the minus-end–directed
motor, cytoplasmic dynein, and components of its associated
regulatory complex, dynactin (Beaudouin et al., 2002; Salina et
al., 2002).
One unresolved question is the identity of the protein or
proteins that couple actin-myosin filaments to the nuclear en-
velope, thereby facilitating the disruption of nuclear integrity
during apoptosis. The leading candidates for this function are
the spectrin family proteins Syne-1 and Syne-2 (of which there
are numerous alternative splice variants and names including
Myne-1/Nesprin-1/Enaptin/CPG2 and Myne-2/Nesprin-2/NU-
ANCE) that have been shown to associate with actin filaments
at their amino-terminal ends (Zhang et al., 2001, 2002; Zhen et
al., 2002; Padmakumar et al., 2004) and insert into the nuclear
membrane at the carboxyl-terminal ends (Apel et al., 2000;
Zhang et al., 2001; Mislow et al., 2002b; Zhen et al., 2002;
Padmakumar et al., 2004), where they may directly bind
A-type lamins (Mislow et al., 2002a,b). Previous research has
demonstrated that disruption of the Syne homologue ANC-1 in
Caenorhabditis elegans leads to defects in nuclear tethering,
which result in aberrant spacing of nuclei in multinucleated
syncytial cells (Starr and Han, 2002). Therefore, we propose
that during apoptosis the Syne proteins contribute to nuclear
disintegration by serving as the physical link that couples the
contraction of actin-myosin filaments to the physical tearing of
the weakened nuclear lamina and membrane. Efforts in our lab-
oratory are currently underway to test this proposal.
Data from the lmna knockout mouse (Sullivan et al.,
1999) and from RNAi studies (Harborth et al., 2001) have
shown that Lamin A/C is not essential for viability. However,
data from the knockout mouse and from human laminopathies
(Burke and Stewart, 2002) indicate that Lamin A/C function is
critical in specific tissues, most notably in skeletal and cardiac
muscle where actin-myosin contractile forces are considerable.
Therefore, we speculate that the viability of cells with mutated
or deleted lmna is compromised in these tissues because actin-
myosin contractile forces are sufficient to disrupt nuclear integ-
rity, leading to cell death. Other tissues are apparently un-
affected, likely due to actin-myosin contractile force being
insufficient to significantly disrupt nuclear integrity.
Certain autoimmune diseases such as systemic lupus
erythematosus are believed to arise due to immunological re-
sponses to nuclear autoantigens released from apoptotic cells.
Treatment with ROCK inhibitor Y-27632 reduced the translo-
cation of the 681 (Shiratsuchi et al., 2003) and D56R/S76R
(Cocca et al., 2002) nuclear autoantigens to plasma mem-
brane blebs and apoptotic bodies without affecting phosphati-
dylserine externalization (Coleman et al., 2001). The results of
this work indicate that ROCK activity is required for actin-
myosin contractile force generation and consequent disruption
of nuclear integrity, which is required for the movement of
DNA and proteins from the nucleus into blebs and apoptotic
bodies. Therefore, ROCK inhibition may have some prophy-
lactic and/or ameliorative benefits for the treatment of specific
autoimmune diseases.
Materials and methods
Cell culture and plasmids
NIH 3T3 and primary MEFs were cultured in DME containing 10% FCS
(Sigma-Aldrich) at 37 C in a 10% CO2 atmosphere. To induce apopto-
sis, cells were placed in serum-free medium for 18 h, and then treated
with 25 ng/ml TNF  (R&D Systems) plus 10  g/ml CHX (Sigma-Aldrich)
for 2 h. For EM, cells were scraped in media and processed as de-
scribed in the section TEM. For Western blotting, cells were scraped
in media, lysed in 1  Laemmli buffer, briefly sonicated to shear DNA,
and heated to 100 C for 5 min before loading equal portions onto
SDS-PAGE.
Rat MLC cDNA (provided by L. Machesky, The University of Bir-
mingham, Edgbaston, Birmingham, UK) was subcloned into the EcoRI re-
striction site of pEGFP-N3 (CLONTECH Laboratories, Inc.). Mutation of
Thr18 Ser19 sites to Ala was done using a QuikChange site-directed mu-
tagenesis kit (Stratagene) according to instructions. Human ROCK I:ER
was made by subcloning a blunt-ended PCR product encoding amino ac-
ids 2–537 into filled-in ScaI–EcoRI sites of pBABE puro EGFP:Raf-1:ER
(Woods et al., 1997; provided by M. McMahon, University of California
San Francisco Comprehensive Cancer Center, San Francisco, CA). Muta-
tion of Lys105 to Gly was done with QuikChange.
BOSC 293 ecotropic retroviral packaging cells were transfected
with pBABE puro ROCK I:ER or KD:ER plasmid using Effectene (QIA-
GEN) according to instructions. After 36 h, supernatant was collected,
centrifuged at 14,000 rpm for 15 min, and aliquots were stored at
 80 C. Exponentially growing NIH 3T3 or MEFs were infected with un-
diluted retroviral supernatant mixed with 4  g/ml polybrene (Sigma-
Aldrich) and selected with 2.5  g/ml puromycin (Sigma-Aldrich) to estab-
lish transduced pools.
Cytochalasin D, 4-HT, and swinholide A were from purchased from
Sigma-Aldrich, z-VAD-fmk and staurosporine were purchased from BIO-
MOL Research Laboratories, Inc., and Y-27632 and Latrunculin B were
purchased from Calbiochem.
Figure 9. ROCK I does not activate caspases. Wild-type and lamin A/C
null MEFs expressing ROCK I:ER or kinase dead KD:ER were left untreated
or treated with 1  M 4-HT, either in the absence or presence of z-VAD-fmk
as indicated. As a positive control for caspase activation, cells were
treated with 25 ng/ml TNF  plus 10  g/ml CHX. Western blotting re-
vealed that 4-HT treatment of KD:ER- or ROCK I:ER-expressing wild-type
and lamin A/C null fibroblasts did not induce cleavage of lamin B1 (A) or
PARP (B) although each was cleaved in response to TNF  treatment.
(C) Western blotting for ERK2 reflects protein levels across samples.JCB • VOLUME 168 • NUMBER 2 • 2005 254
TEM
Cell suspensions were pelleted by centrifugation, resuspended in 1 ml of
fixative in an Eppendorf tube and immediately spun down again to form a
pellet, and stored overnight at 4 C. Samples were postfixed in 2% osmium
tetroxide, dehydrated through a graded series of ethanols, infiltrated, and
embedded in Epon. For light microscopy, 1.0- m sections were cut, dried
onto microscope slides, and stained with toluidine blue. For EM, 75-nm
sections were collected onto copper grids, double stained with uranyl ace-
tate and bismuth subnitrite, and examined in a transmission electron mi-
croscope (model 1010 Jem; JEOL) at 80 Kv accelerating voltage. Digital
images were collected using a CCD camera (model 2k; Hamamatsu)
aided with AMT 12-HR software.
Western blot analysis
After treatment as described in the figure legends, cells were lysed in 1 
Laemmli sample buffer, sonicated, and electrophoresed on 10% SDS-PAGE
before electro-transfer to nitrocellulose membranes. Blots were probed with
antibodies against lamins B1 and A/C (Santa Cruz Biotechnology, Inc.),
PARP (BD Biosciences),  -tubulin (Amersham Biosciences), GFP (CLON-
TECH Laboratories, Inc.), phospho-MLC (Thr18/Ser19), cleaved caspase 3
(Asp 175; Cell Signaling), MLC (Sigma-Aldrich), phospho-MYPT1 (Thr696;
Upstate Biotechnology), MYPT1 (Covance), ROCK I (BD Biosciences), phos-
pho-Ezrin (Thr567; Cell Signaling), Ezrin (Upstate Biotechnology), ER 
(Santa Cruz Biotechnology, Inc.), phospho-LIMK1(Thr508)/LIMK2(Thr505)
(Cell Signaling), LIMK1 (Cell Signaling), ERK2 (provided by C.J. Marshall,
The Institute for Cancer Research, London, UK), Nup153 (provided by B.
Burke, University of Florida College of Medicine, Gainesville, FL), or LAP2 
(provided by R. Foisner, Vienna Biocenter, Vienna, Austria) and appropri-
ate HRP-conjugated secondary antibodies (Pierce Chemical Co.) followed
by visualization with ECL (Amersham Biosciences) or SuperSignal West
Femto (Pierce Chemical Co.) according to instructions and exposure to
BioMax autoradiographic film (Kodak).
FACS sorting and analysis
NIH 3T3 cells were transfected with pEGFP-N3 (CLONTECH Laboratories,
Inc.), pEGFP-N3 MLC-GFP, or pEGFP-N3 MLC(TASA)-GFP using Lipo-
fectamine as described previously (Coleman et al., 2001). GFP-expressing
cells were detached with trypsin, sorted, and collected using a FACSVan-
tageSE cell sorter (BD Biosciences). The machine has a Coherent 90 C-4
argon ion laser that is tuned to 488 nm. This light was used to excite GFP,
which was measured at 515–545 nm.
Immunofluorescence
NIH 3T3 and primary MEFs were fixed in 4% PFA, permeabilized with
0.5% Triton X-100, and stained in PBS with goat anti–lamin B1 antibody
(Santa Cruz Biotechnology, Inc.) at 1:500 dilution followed by FITC-conju-
gated donkey anti–goat antibody (Jackson ImmunoResearch Laboratories)
at 1:200 dilution, or with mouse anti– -tubulin (Sigma-Aldrich) at 1:200
dilution and FITC-conjugated donkey anti–mouse antibody (Jackson Immu-
noResearch Laboratories) at 1:200 dilution. Filamentous actin structures
were stained with 1:250 dilution of Texas red–conjugated phalloidin (Mo-
lecular Probes). DNA fragmentation by TUNEL was done with a DeadEnd
Fluorometric TUNEL kit (Promega) according to the manufacturer’s instruc-
tions. Coverslips were mounted in Mowiol and visualized using a confocal
microscope (model MRC1024; Bio-Rad Laboratories).
We would like to acknowledge the technical assistance of Ian Titley, Leslie
Turner, Ryan Wychowanec, Neelima Shah, and Qian Chun Yu. We thank
Chris Marshall for anti-ERK2, Brian Burke for anti-Nup153, Roland Foisner for
anti-LAP2  antibodies, Laura Machesky for MLC, and Martin McMahon for
Raf:ER plasmids.
This work was supported by American Cancer Society (RGS-04-078-
01-TBE) and National Institutes of Health (CA030721) grants to M.F. Olson.
Initial support provided by The Royal Society and Cancer Research UK at the
Institute of Cancer Research, London, UK. The authors declare that they have
no competing financial interests.
Submitted: 9 September 2004
Accepted: 17 November 2004
References
Amano, T., K. Tanabe, T. Eto, S. Narumiya, and K. Mizuno. 2001. LIM-kinase
2 induces formation of stress fibres, focal adhesions and membrane
blebs, dependent on its activation by Rho-associated kinase-catalysed
phosphorylation at threonine-505. Biochem. J. 354:149–159.
Apel, E.D., R.M. Lewis, R.M. Grady, and J.R. Sanes. 2000. Syne-1, a dystro-
phin- and Klarsicht-related protein associated with synaptic nuclei at the
neuromuscular junction. J. Biol. Chem. 275:31986–31995.
Beaudouin, J., D. Gerlich, N. Daigle, R. Eils, and J. Ellenberg. 2002. Nuclear
envelope breakdown proceeds by microtubule-induced tearing of the
lamina. Cell. 108:83–96.
Broers, J.L., N.M. Bronnenberg, H.J. Kuijpers, B. Schutte, C.J. Hutchison, and
F.C. Ramaekers. 2002. Partial cleavage of A-type lamins concurs with
their total disintegration from the nuclear lamina during apoptosis. Eur.
J. Cell Biol. 81:677–691.
Bubb, M.R., I. Spector, A.D. Bershadsky, and E.D. Korn. 1995. Swinholide A is
a microfilament disrupting marine toxin that stabilizes actin dimers and
severs actin filaments. J. Biol. Chem. 270:3463–3466.
Burke, B., and J. Ellenberg. 2002. Remodelling the walls of the nucleus. Nat.
Rev. Mol. Cell Biol. 3:487–497.
Burke, B., and C.L. Stewart. 2002. Life at the edge: the nuclear envelope and
human disease. Nat. Rev. Mol. Cell Biol. 3:575–585.
Chiarini, A., J.F. Whitfield, U. Armato, and I. Dal Pra. 2002. Protein kinase
C-beta II Is an apoptotic lamin kinase in polyomavirus-transformed, eto-
poside-treated pyF111 rat fibroblasts. J. Biol. Chem. 277:18827–18839.
Clubb, B.H., and M. Locke. 1998a. 3T3 cells have nuclear invaginations con-
taining F-actin. Tissue Cell. 30:684–691.
Clubb, B.H., and M. Locke. 1998b. Peripheral nuclear matrix actin forms peri-
nuclear shells. J. Cell. Biochem. 70:240–251.
Cocca, B.A., A.M. Cline, and M.Z. Radic. 2002. Blebs and apoptotic bodies are
B cell autoantigens. J. Immunol. 169:159–166.
Coleman, M.L., and M.F. Olson. 2002. Rho GTPase signalling pathways in
the morphological changes associated with apoptosis. Cell Death Differ.
9:493–504.
Coleman, M.L., E.A. Sahai, M. Yeo, M. Bosch, A. Dewar, and M.F. Olson.
2001. Membrane blebbing during apoptosis results from caspase-medi-
ated activation of ROCK I. Nat. Cell Biol. 3:339–345.
Croft, D.R., E. Sahai, G. Mavria, S. Li, J. Tsai, W.M.F. Lee, C.J. Marshall, and
M.F. Olson. 2004. Conditional ROCK activation in vivo induces tumor
cell dissemination and angiogenesis. Cancer Res. 64:8994–9001.
Cross, T., G. Griffiths, E. Deacon, R. Sallis, M. Gough, D. Watters, and J.M.
Lord. 2000. PKC-delta is an apoptotic lamin kinase. Oncogene. 19:
2331–2337.
Feng, J., M. Ito, K. Ichikawa, N. Isaka, M. Nishikawa, D.J. Hartshorne, and T. Na-
kano. 1999. Inhibitory phosphorylation site for Rho-associated kinase on
smooth muscle myosin phosphatase. J. Biol. Chem. 274:37385–37390.
Gautreau, A., D. Louvard, and M. Arpin. 2000. Morphogenic effects of ezrin re-
quire a phosphorylation-induced transition from oligomers to monomers
at the plasma membrane. J. Cell Biol. 150:193–203.
Harborth, J., S.M. Elbashir, K. Bechert, T. Tuschl, and K. Weber. 2001. Identifi-
cation of essential genes in cultured mammalian cells using small inter-
fering RNAs. J. Cell Sci. 114:4557–4565.
Heald, R., and F. McKeon. 1990. Mutations of phosphorylation sites in lamin A
that prevent nuclear lamina disassembly in mitosis. Cell. 61:579–589.
Iwasaki, T., M. Murata-Hori, S. Ishitobi, and H. Hosoya. 2001. Diphosphorylated
MRLC is required for organization of stress fibers in interphase cells and
the contractile ring in dividing cells. Cell Struct. Funct. 26:677–683.
Kawano, Y., Y. Fukata, N. Oshiro, M. Amano, T. Nakamura, M. Ito, F. Mat-
sumura, M. Inagaki, and K. Kaibuchi. 1999. Phosphorylation of myosin-
binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo. J.
Cell Biol. 147:1023–1038.
Kerr, J.F., A.H. Wyllie, and A.R. Currie. 1972. Apoptosis: a basic biological
phenomenon with wide-ranging implications in tissue kinetics. Br. J.
Cancer. 26:239–257.
Leung, T., X.Q. Chen, E. Manser, and L. Lim. 1996. The p160 RhoA-binding
kinase ROK alpha is a member of a kinase family and is involved in the
reorganization of the cytoskeleton. Mol. Cell. Biol. 16:5313–5327.
McMahon, M. 2001. Steroid receptor fusion proteins for conditional activation
of Raf-MEK-ERK signaling pathway. Methods Enzymol. 332:401–417.
McMullan, R., S. Lax, V.H. Robertson, D.J. Radford, S. Broad, F.M. Watt, A.
Rowles, D.R. Croft, M.F. Olson, and N.A. Hotchin. 2003. Keratinocyte
differentiation is regulated by the Rho and ROCK signaling pathway.
Curr. Biol. 13:2185–2189.
Mislow, J.M., J.M. Holaska, M.S. Kim, K.K. Lee, M. Segura-Totten, K.L. Wil-
son, and E.M. McNally. 2002a. Nesprin-1alpha self-associates and binds
directly to emerin and lamin A in vitro. FEBS Lett. 525:135–140.
Mislow, J.M., M.S. Kim, D.B. Davis, and E.M. McNally. 2002b. Myne-1, a
spectrin repeat transmembrane protein of the myocyte inner nuclear
membrane, interacts with lamin A/C. J. Cell Sci. 115:61–70.ACTIN-MYOSIN AND APOPTOTIC NUCLEAR DISINTEGRATION • CROFT ET AL. 255
Neamati, N., A. Fernandez, S. Wright, J. Kiefer, and D.J. McConkey. 1995.
Degradation of lamin B1 precedes oligonucleosomal DNA fragmenta-
tion in apoptotic thymocytes and isolated thymocyte nuclei. J. Immunol.
154:3788–3795.
Ohashi, K., K. Nagata, M. Maekawa, T. Ishizaki, S. Narumiya, and K. Mizuno.
2000. Rho-associated kinase ROCK activates LIM-kinase 1 by phos-
phorylation at threonine 508 within the activation loop. J. Biol. Chem.
275:3577–3582.
Padmakumar, V.C., S. Abraham, S. Braune, A.A. Noegel, B. Tunggal, I. Kar-
akesisoglou, and E. Korenbaum. 2004. Enaptin, a giant actin-binding
protein, is an element of the nuclear membrane and the actin cytoskele-
ton. Exp. Cell Res. 295:330–339.
Rao, L., D. Perez, and E. White. 1996. Lamin proteolysis facilitates nuclear
events during apoptosis. J. Cell Biol. 135:1441–1455.
Rosen, A., and L. Casciola-Rosen. 1999. Autoantigens as substrates for apop-
totic proteases: implications for the pathogenesis of systemic autoim-
mune disease. Cell Death Differ. 6:6–12.
Salina, D., K. Bodoor, D.M. Eckley, T.A. Schroer, J.B. Rattner, and B. Burke.
2002. Cytoplasmic dynein as a facilitator of nuclear envelope breakdown.
Cell. 108:97–107.
Sampath, P., and T.D. Pollard. 1991. Effects of cytochalasin, phalloidin, and pH
on the elongation of actin filaments. Biochemistry. 30:1973–1980.
Sebbagh, M., C. Renvoize, J. Hamelin, N. Riche, J. Bertoglio, and J. Breard.
2001. Caspase-3-mediated cleavage of ROCK I induces MLC phosphor-
ylation and apoptotic membrane blebbing. Nat. Cell Biol. 3:346–352.
Shimizu, T., C.X. Cao, R.G. Shao, and Y. Pommier. 1998. Lamin B phosphory-
lation by protein kinase calpha and proteolysis during apoptosis in hu-
man leukemia HL60 cells. J. Biol. Chem. 273:8669–8674.
Shiratsuchi, A., T. Mori, Y. Takahashi, K. Sakai, and Y. Nakanishi. 2003. A
presumed human nuclear autoantigen that translocates to plasma mem-
brane blebs during apoptosis. J. Biochem. (Tokyo). 133:211–218.
Spector, I., N.R. Shochet, Y. Kashman, and A. Groweiss. 1983. Latrunculins:
novel marine toxins that disrupt microfilament organization in cultured
cells. Science. 219:493–495.
Starr, D.A., and M. Han. 2002. Role of ANC-1 in tethering nuclei to the actin
cytoskeleton. Science. 298:406–409.
Starr, D.A., and M. Han. 2003. ANChors away: an actin based mechanism of
nuclear positioning. J. Cell Sci. 116:211–216.
Stollar, B.D., and F. Stephenson. 2002. Apoptosis and nucleosomes. Lupus.
11:787–789.
Sullivan, T., D. Escalante-Alcalde, H. Bhatt, M. Anver, N. Bhat, K. Nagashima,
C.L. Stewart, and B. Burke. 1999. Loss of A-type lamin expression
compromises nuclear envelope integrity leading to muscular dystrophy.
J. Cell Biol. 147:913–920.
Sumi, T., K. Matsumoto, and T. Nakamura. 2001. Specific activation of LIM ki-
nase 2 via phosphorylation of threonine 505 by ROCK, a Rho-dependent
protein kinase. J. Biol. Chem. 276:670–676.
Tran Quang, C., A. Gautreau, M. Arpin, and R. Treisman. 2000. Ezrin function
is required for ROCK-mediated fibroblast transformation by the Net and
Dbl oncogenes. EMBO J. 19:4565–4576.
Woods, D., D. Parry, H. Cherwinski, E. Bosch, E. Lees, and M. McMahon.
1997. Raf-induced proliferation or cell cycle arrest is determined by the
level of Raf activity with arrest mediated by p21Cip1. Mol. Cell. Biol.
17:5598–5611.
Zhang, Q., J.N. Skepper, F. Yang, J.D. Davies, L. Hegyi, R.G. Roberts, P.L.
Weissberg, J.A. Ellis, and C.M. Shanahan. 2001. Nesprins: a novel fam-
ily of spectrin-repeat-containing proteins that localize to the nuclear
membrane in multiple tissues. J. Cell Sci. 114:4485–4498.
Zhang, Q., C. Ragnauth, M.J. Greener, C.M. Shanahan, and R.G. Roberts. 2002.
The nesprins are giant actin-binding proteins, orthologous to Drosophila
melanogaster muscle protein MSP-300. Genomics. 80:473–481.
Zhen, Y.Y., T. Libotte, M. Munck, A.A. Noegel, and E. Korenbaum. 2002.
NUANCE, a giant protein connecting the nucleus and actin cytoskeleton.
J. Cell Sci. 115:3207–3222.